Takayasu's arteritis causes chronic inflammation, mainly of the aorta (the artery that connects directly with the heart), the arteries that branch off from it, and the pulmonary arteries.
Takayasu's arteritis is rare. It affects mostly women aged 15 to 30. Its cause is unknown.
The aorta and its branches, including arteries that take blood to the head and the kidneys, become inflamed. In about half of people, the pulmonary arteries are also affected. Inflammation may cause sections of these arteries to become narrow or blocked. The walls may weaken and stretch, resulting in a bulge (aneurysm). The affected vessels cannot provide enough blood to the tissues they supply.
Takayasu's arteritis is a chronic disorder with symptoms that fluctuate in severity.
Sometimes the disorder begins with fevers, muscle and joint aches, loss of appetite, weight loss, and night sweats. But usually, symptoms occur when an artery narrows, reducing blood flow to part of the body, as in the following:
Some people do not have any symptoms. In other people, the disorder progresses, causing serious complications such as strokes, heart failure, heart attacks, kidney failure, and aneurysms.
Doctors suspect the disorder based on the following, especially in young women:
Doctors ask about symptoms, review the person's medical history, and do a complete physical examination to exclude other disorders that may cause similar symptoms.
Blood and urine tests are done. They cannot identify the disorder but may confirm that inflammation is present.
To confirm the diagnosis, doctors may use angiography—conventional, magnetic resonance, or computed tomography (CT) angiography—to evaluate the aorta and its branches. For conventional or CT angiography, a dye that can be seen on x-rays (radiopaque dye) is injected into blood vessels to outline them. Then x-rays are taken. Magnetic resonance angiography does not require the injection of a dye. These procedures can detect aneurysms and show where the arteries are narrowed.
After Takayasu's arteritis is diagnosed, regular doctor visits should be scheduled so that the doctor can check whether the disorder is progressing.
Corticosteroids (such as prednisone) are usually used. They effectively reduce inflammation in most people. Sometimes another drug that suppresses the immune system (immunosuppressant), such as azathioprine, cyclophosphamide, mycophenolate mofetil, or methotrexate, is also used. Tumor necrosis factor inhibitors, such as infliximab and etanercept, may also be effective. However, drugs cannot control symptoms in about one fourth of people.
How long drugs should be given has not been determined. The dose of the corticosteroid is gradually reduced, and the drug is eventually stopped because these drugs, especially when used for a long time, can have serious side effects. When drugs are stopped, symptoms return in about one half of people, so the drugs may need to be restarted.
High blood pressure must be controlled to prevent complications (see High Blood Pressure: Treatment). Angiotensin-converting enzyme (ACE) inhibitors are often used. Taking a low dose of aspirin is usually recommended to help decrease the risk of clotting in the inflamed artery, which can lead to blockages. If an artery that supplies the heart is blocked, a heart attack can result.
If people have difficulty using their arms or walking, bypass surgery may be done to restore the blood flow to the affected limb. Other procedures to restore blood flow (such as coronary artery bypass surgery or percutaneous transluminal coronary angioplasty) may be needed, depending on the symptoms.
Last full review/revision April 2008 by Carmen E. Gota, MD